and Cartoon Network. When Regular Show first landed in 2010, nobody quite knew how much of a hit the animated show would become. Then, 244 episodes and five Emmy nominations later (plus one win!), ...

Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company developing small-molecule N-myristoyltransferase inhibitors (NMTis) as targeted therapies for the treatment of ...

Medication illustration (Pxhere/Creative Commons). Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps. As advertised ...

ADC works like a guided missile that hits cancerous cells while sparing the healthy ones, and has the potential to replace chemotherapy. Daiichi has emerged as a leader in this space following the ...

The drugmaker is also working with external contract manufacturers to expand production of the so-called antibody drug conjugates (ADCs). He speaks with Shery Ahn on "Bloomberg: The Asia Trade".

Daiichi Sankyo Co. will seek to maintain its edge over competitors in precision cancer therapies, by pushing ahead with clinical trials of drug candidates being developed using new technology ...

The drugmaker believes its next generation of "antibody drug conjugate" (ADC) medicines that show promise in early stage human testing will help keep the company ahead of the pack, its President ...

Dove has extended its Self-Esteem Project to reach a younger audience through a partnership with live-action preschool brand Blippi. This year marks Dove's 20-year history of building body confidence ...

Ono Pharmaceutical has bought a seat in a quiet corner of the congested antibody-drug conjugate (ADC) space, agreeing to pay LigaChem Biosciences up to $700 million for a potential first-in-class ...